Progression Patterns of Choroidal Venous Alterations (CVA)

November 21, 2025 updated by: Gemmy Cheung Chui Ming, Singapore National Eye Centre

International Multi-centre, Prospective, Longitudinal Cohort to Evaluate the Progression Pattern of Choroidal Venous Alterations

This study is about understanding how a condition called pachychoroid changes over time. Pachychoroid refers to an anatomic choroidal characteristic with abnormally thick choroid or abnormally dilated Haller's vessels. Pachychoroid can range from mild forms which does not cause any problems to more serious ones that might cause vision loss.This study will recruit participants with pachychoroid, to learn more about how this condition develops, how it affects people in the long run, and what factors might make it worse.

Study Overview

Status

Recruiting

Detailed Description

This study aims to document the longitudinal progression pattern and the incidence rate of progression of choroidal venous alteration (defined as either an increase in number of quadrants with pachyvessels or formation of new anastomoses which violates the physiological watershed It will provide valuable natural history data to study the pattern of evolution of choroidal vessels over time and validate the proposed multi-hit theory over a period of three years.

Study Type

Observational

Enrollment (Estimated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • Not yet recruiting
        • Hong Kong University
        • Contact:
      • Kuala Lumpur, Malaysia
        • Recruiting
        • University of Malaya Medical Centre
        • Contact:
      • Singapore, Singapore
        • Not yet recruiting
        • National University Hospital, Singapore
        • Contact:
      • Singapore, Singapore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This study will aim to recruit 170 participants in Singapore National Eye Centre (SNEC) and 50 participants in National University Hospital, 30 participants from the University of Malaya

Description

Inclusion Criteria:

  1. Adults aged 45 years or older.
  2. Presence of pachyvessels on ultra-widefield (UWF) imaging in at least one quadrant.
  3. Willing to undergo pupil dilation, and protocol-required procedures for both eyes
  4. Willing to provide written informed consent

Exclusion Criteria:

  1. Presence of disorders of the ocular media which interfere with visual acuity and other ocular assessments during the study period
  2. Eyes with other ocular pathology such as trauma, inflammation, previous intraocular surgery (except for cataract surgery)
  3. Systemic diseases that might affect ocular blood flow such as uncontrolled hypertension, autoimmune disease, and haematological disorders
  4. Pregnant or nursing women
  5. Persons who are unable to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Progression of choroidal venous alterations
Time Frame: 3 years
Proportion of eyes demonstrating progression of choroidal venous alterations, defined as either an increase in number of quadrants with pachyvessels or formation of new choroidal anastomoses.
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of progression of pachychoroid disease manifestation
Time Frame: 3 years
New onset of Central Serous Chorioretinopathy (CSCR), focal Retinal Pigment Epithelium (RPE) changes, or other pachychorois related findings.
3 years
Risk factors associated with progression of choroidal venous alteration
Time Frame: 3 years
Assessment of demographic, cilinical, and imaging parameters associated with progression.
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2025

Primary Completion (Estimated)

June 1, 2029

Study Completion (Estimated)

August 1, 2029

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Estimated)

November 19, 2025

Study Record Updates

Last Update Posted (Actual)

November 28, 2025

Last Update Submitted That Met QC Criteria

November 21, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-4359

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pachychoroid Disease

Subscribe